Cancer trial asks: is more chemo always better?
NCT ID NCT03301454
Summary
This study tested whether patients with advanced esophageal cancer should continue chemotherapy after an initial 6-week treatment if their disease hasn't progressed. All participants received 6 weeks of chemotherapy first. Those whose cancer hadn't grown were then randomly assigned to either continue chemotherapy or stop it and receive supportive care only. The goal was to see which approach better controlled the cancer and improved survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER, SQUAMOUS CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre François Baclesse
Caen, 14076, France
-
Centre Hospitalier de Boulogne sur mer
Boulogne-sur-Mer, 62200, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Centre René Gauducheau
Nantes, 44805, France
-
Hôpital Privé Arras Les Bonnettes
Arras, 62000, France
Conditions
Explore the condition pages connected to this study.